BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26235803)

  • 1. Estimation of total kidney volume in autosomal dominant polycystic kidney disease.
    Spithoven EM; van Gastel MD; Messchendorp AL; Casteleijn NF; Drenth JP; Gaillard CA; de Fijter JW; Meijer E; Peters DJ; Kappert P; Renken RJ; Visser FW; Wetzels JF; Zietse R; Gansevoort RT; ;
    Am J Kidney Dis; 2015 Nov; 66(5):792-801. PubMed ID: 26235803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression.
    Kline TL; Korfiatis P; Edwards ME; Warner JD; Irazabal MV; King BF; Torres VE; Erickson BJ
    Nephrol Dial Transplant; 2016 Feb; 31(2):241-8. PubMed ID: 26330562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited Performance of Estimated Total Kidney Volume for Follow-up of ADPKD.
    Demoulin N; Nicola V; Michoux N; Gillion V; Ho TA; Clerckx C; Pirson Y; Annet L
    Kidney Int Rep; 2021 Nov; 6(11):2821-2829. PubMed ID: 34805634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic Measurement of Kidney and Liver Volumes from MR Images of Patients Affected by Autosomal Dominant Polycystic Kidney Disease.
    van Gastel MDA; Edwards ME; Torres VE; Erickson BJ; Gansevoort RT; Kline TL
    J Am Soc Nephrol; 2019 Aug; 30(8):1514-1522. PubMed ID: 31270136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
    Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
    Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease.
    Sharma K; Caroli A; Quach LV; Petzold K; Bozzetto M; Serra AL; Remuzzi G; Remuzzi A
    PLoS One; 2017; 12(5):e0178488. PubMed ID: 28558028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.
    Simms RJ; Doshi T; Metherall P; Ryan D; Wright P; Gruel N; van Gastel MDA; Gansevoort RT; Tindale W; Ong ACM
    Eur Radiol; 2019 Aug; 29(8):4188-4197. PubMed ID: 30666443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
    Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.
    Spithoven EM; Meijer E; Boertien WE; Sinkeler SJ; Tent H; de Jong PE; Navis G; Gansevoort RT
    Am J Kidney Dis; 2013 Sep; 62(3):531-40. PubMed ID: 23714171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney volume estimations with ellipsoid equations by magnetic resonance imaging in autosomal dominant polycystic kidney disease.
    Higashihara E; Nutahara K; Okegawa T; Tanbo M; Hara H; Miyazaki I; Kobayasi K; Nitatori T
    Nephron; 2015; 129(4):253-62. PubMed ID: 25895545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease.
    van Gastel MDA; Messchendorp AL; Kappert P; Kaatee MA; de Jong M; Renken RJ; Ter Horst GJ; Mahesh SVK; Gansevoort RT;
    Abdom Radiol (NY); 2018 May; 43(5):1215-1222. PubMed ID: 28871393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Performance of Kidney Volume Measurement for Polycystic Kidney Disease: A Comparative Study of Ellipsoid vs. Manual Segmentation.
    Shi B; Akbari P; Pourafkari M; Iliuta IA; Guiard E; Quist CF; Song X; Hillier D; Khalili K; Pei Y
    Sci Rep; 2019 Jul; 9(1):10996. PubMed ID: 31358787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Averaging Measurements From Multiple MRI Pulse Sequences on Kidney Volume Reproducibility in Autosomal Dominant Polycystic Kidney Disease.
    Dev H; Zhu C; Sharbatdaran A; Raza SI; Wang SJ; Romano DJ; Goel A; Teichman K; Moghadam MC; Shih G; Blumenfeld JD; Shimonov D; Chevalier JM; Prince MR
    J Magn Reson Imaging; 2023 Oct; 58(4):1153-1160. PubMed ID: 36645114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisterna chyli in autosomal dominant polycystic kidney disease.
    Thimmappa ND; Blumenfeld JD; Cerilles MA; Dunning A; Donahue SL; Bobb WO; Zhang HL; Prince MR
    J Magn Reson Imaging; 2015 Jan; 41(1):142-8. PubMed ID: 24470398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
    Kline TL; Korfiatis P; Edwards ME; Bae KT; Yu A; Chapman AB; Mrug M; Grantham JJ; Landsittel D; Bennett WM; King BF; Harris PC; Torres VE; Erickson BJ;
    Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of Total Renal Volume Computation in Polycystic Kidney Disease From Magnetic Resonance Imaging.
    Turco D; Severi S; Mignani R; Aiello V; Magistroni R; Corsi C
    Acad Radiol; 2015 Nov; 22(11):1376-84. PubMed ID: 26276168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment.
    Turco D; Busutti M; Mignani R; Magistroni R; Corsi C
    Am J Nephrol; 2017; 45(5):373-379. PubMed ID: 28315882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP).
    O'Neill WC; Robbin ML; Bae KT; Grantham JJ; Chapman AB; Guay-Woodford LM; Torres VE; King BF; Wetzel LH; Thompson PA; Miller JP
    Am J Kidney Dis; 2005 Dec; 46(6):1058-64. PubMed ID: 16310571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel three-dimensional imaging volumetry in autosomal dominant polycystic kidney disease: comparison with 2D volumetry.
    Shin D; Lee KB; Hyun YY; Lee YR; Hwang YH; Park HC; Ahn C
    Clin Nephrol; 2014 Aug; 82(2):98-106. PubMed ID: 25029513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging 3T and total fibrotic volume in autosomal dominant polycystic kidney disease.
    Lai S; Mastroluca D; Letizia C; Petramala L; Perrotta AM; DiGaeta A; Ferrigno L; Ciccariello M; D'Angelo AR; Panebianco V
    Intern Med J; 2018 Dec; 48(12):1505-1513. PubMed ID: 30043487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.